Archive for the 'Tuberculosis' Category


Text Messages Could Help Tuberculosis Drug Compliance

Use of mobile phone text-messaging (or short message service/SMS as it is also known) could help tuberculosis patients in the world's most remote locations adhere to their treatment. The promising early results of this strategy are discussed in the World Report in this week's edition of The Lancet, written by freelance journalist Eliza Barclay.
(more...)


01/02/2009 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Bovine TB Infection Still Threatens Human Health In The UK

Bovine tuberculosis (TB) still remains a threat to human health in the UK, although the overall risk of infection is considered to be small, reveals research published in the journal Thorax. The researchers detail three cases of TB infection arising in rural Cornwall, South West England. Two confirmed cases of bovine TB caused by Mycobacterium bovis arose in a woman and her pet dog.
(more...)


01/02/2009 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

New Mexico, Texas, Colorado Alerts Bus Passengers To TB Case That Traveled In August

The New Mexico, Colorado, and Texas Departments of Health announced today that a person recently diagnosed with infectious tuberculosis (TB) in New Mexico traveled on an interstate commercial bus that originated from El Paso, Texas. The bus traveled through New Mexico to its final destination of Greeley, Colorado.
(more...)


12/09/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Gates Foundation Awards Grant For Development Of A Database To Accelerate Discovery Of New Therapies Against Tuberculosis

Collaborative Drug Discovery, Inc. (CDD) today announced that it has received a grant for $1,896,923 from the Bill & Melinda Gates Foundation to develop a collaborative database that will enable scientists to archive, mine, and selectively collaborate around their research data to discover new cures for tuberculosis (TB). The TB bacillus infects approximately one third of the world's population and the disease kills over 1.5 million people every year.
(more...)


11/19/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Cellular Safety Shelters Allow TB Agent To Survive In Infected Individuals

"Foamy" macrophage formation may be the key to persistence of infection by Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, explains a study published November 14 in the open-access journal PLoS Pathogens. These immunity-related cells are shown to be a safety reservoir where the bacterium can hide for years in infected individuals, before inducing an active disease.
(more...)


11/14/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Newly Discovered Protein May Help Explain Tuberculosis’ Resiliency - Experts Find Another Reason Why The Bacterium Is So Nasty

Weill Cornell scientists have located a protein produced by the tuberculosis bacterium that may tell researchers more about how the invader lives so resiliently inside of the body. Dr. Benjamin Gold, working with Dr. Carl Nathan, chairman of microbiology and immunology at Weill Cornell Medical College and their colleagues, located a protein called mycobacterial metallothionein (MymT), which acts like a shield to protect the tuberculosis bacterium from the body's natural defenses.
(more...)


11/07/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

The Union Announces A Successful Trial Of A TB Candidate Vaccine To Prevent Tuberculosis Among HIV-infected Patients

The International Union Against Tuberculosis and Lung Disease (The Union), an international organisation established in 1920 to fight TB and promote lung health worldwide, today announces the successful results of a TB candidatevaccine trial for HIV-infected patients. As a fact, Tuberculosis and HIV are inextricably intertwined since the risk of developing tuberculosis in persons carrying HIV is a lifetime risk.
(more...)


10/27/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Extensively Resistant Tuberculosis: A Ray Of Hope Is Announced In Berlin - Breakthrough By German And Italian Researchers

Although the dreaded extensively resistant tuberculosis is already advancing on us and doctors have been unable to save a number of sufferers, a new, promising treatment based on linezolid has been successfully trialled by German and Italian researchers. They presented their preliminary results to the Annual Congress of the European Respiratory Society (ERS) in Berlin. The classical treatment scheme for tuberculosis theoretically cures approximately 80% of patients.
(more...)


10/06/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

Tuberculosis Hospitalizations Fall 41 Percent, USA

Hospitalizations for tuberculosis fell from 15,000 in 1995 to 8,800 in 2006, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. However, the number of hospitalizations for patients who were hospitalized for other conditions but who also had tuberculosis only fell about 10 percent to 49,700 in 2006 from 55,500 in 1995. Tuberculosis - often called TB - is an infectious disease that mostly attacks the lungs.
(more...)


10/01/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

PolyMedix Presents Data On Anti-Tuberculosis Activity Of Its Novel Antibiotic Compounds

PolyMedix, Inc. an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, presented new data at the "New Directions in AIDS Treatment Research Policy and Care Symposium" in New York on September 26th, 2008.
(more...)


09/30/2008 | Respiratory & Asthma - Tuberculosis | Trackback | Comments Off

« Previous Entries

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

- -

>-- Top of Page --<